Östberg, L.

hbsag tuvirumab antibody patient anti-hb complex hbsag /tuvirumab complexes therapy assay level phase hepatitis heijtink procedure conjugate sample anti-hbs antibodies anti-tuvirumab serum tuvirumab /hbsag complexes /tuvirumab virus inhibition tuvirumab antibodies administration erasmus university rotterdam circulation reference monitoring hepatitis b preparation square triangle reduction amount study detection hepatect treatment lamivudine f 4-7b conjugate concentration follow-up phase anti-tuvirumab antibody hbsag particles infection hbsag levels phase anti-tuvirumab antibodies pre-treatment phase anti-tuvirumab f 4-7b reference hbsag hbsag /anti complexes hepatitis b patients result antigen epitope particle rotterdam table i phase antibodies polyclonal quantitation mouse surface infusion 0.02 experiment activity /hbsag antihb /anti hbs.ot patient h complexed hbsag assay reference anti-hbs virus transfer patients b liver